3rd Quarter - Report

CAPITOL CONSULTING GROUP, LLC for TERUMO BCT (FORMERLY CARIDIANBCT BIOTECHNOLOGIES LLC)

Firm
Client
Income
$10,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Medical/Disease Research/Clinical Labs MED

Blood pathogen reduction technology development

Foreign entity interest: Owner

LobbyistCovered position, as disclosed
LYNN HENSELMAN —
PATRICK HIU —
GILLIAN JAEGER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Health Issues HCR

Blood pathogen reduction technology development

Foreign entity interest: Owner

LobbyistCovered position, as disclosed
LYNN HENSELMAN —
PATRICK HIU —
GILLIAN JAEGER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Defense DEF

Blood pathogen reduction technology development

Foreign entity interest: Owner

LobbyistCovered position, as disclosed
LYNN HENSELMAN —
PATRICK HIU —
GILLIAN JAEGER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.